Metformin has been demonstrated to attenuate hyperglycaemia by modulating the gut microbiota.
However, the mechanisms through which the microbiome mediates metformin monotherapy failure (MMF) are unclear.
Herein, in a prospective clinical cohort study of newly diagnosed type 2 diabetes mellitus (T2DM) patients treated with metformin monotherapy, metagenomic sequencing of faecal samples revealed that
